基于影像组学特征的列线图预测较低级别胶质瘤端粒酶逆转录酶启动子突变状态及预后
回顾性纳入176例较低级别胶质瘤患者(训练集123例、验证集53例),从增强MRI提取851个影像组学特征,经LASSO筛选7个特征并计算rad-score,结合年龄和性别构建影像组学列线图预测TERT启动子突变状态;训练集AUC为0.900(0.832-0.946),验证集AUC为0.873(0.753-0.948);中位总生存时间28.5个月,列线图将患者分为预后显著不同的两个风险组(log-rank=47.531,p<0.001)。
要点
- 基于增强MRI的影像组学列线图可无创预测较低级别胶质瘤TERT启动子突变状态。
- 列线图在训练集AUC为0.900(0.832-0.946),验证集AUC为0.873(0.753-0.948)。
- 列线图可将患者分为预后显著不同的两个风险组(log-rank=47.531,p<0.001)。
核心结论
- 基于影像组学特征的列线图是术前无创预测TERT启动子突变状态和评估较低级别胶质瘤患者预后的有前景的方法。
研究设计与样本
- 回顾性纳入176例较低级别胶质瘤患者,训练集123例、验证集53例;从增强MRI图像提取851个影像组学特征,采用LASSO方法筛选特征并计算rad-score,基于rad-score、年龄和性别构建多变量逻辑回归影像组学标签及列线图。
诊断标准与关键数值
- LASSO筛选出7个稳健影像组学特征;影像组学标签预测TERT启动子突变状态的AUC在训练集为0.900(0.832-0.946),在验证集为0.873(0.753-0.948);中位总生存时间28.5个月,基于TERT启动子突变状态和影像组学标签进行预后分层,两风险组预后差异显著(log-rank=47.531,p<0.001)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
AIM: To explore the predictive value of the radiomics feature-based nomogram for predicting telomerase reverse transcriptase (TERT) promoter mutation status and prognosis of lower-grade gliomas (LGGs) non-invasively.
MATERIALS AND METHODS: One hundred and seventy-six LGG patients (123 in the training cohort and 53 in the validation cohort) were enrolled retrospectively. A total of 851 radiomics features were extracted from contrast-enhanced magnetic resonance imaging (MRI) images. The radiomics features were selected using the least absolute shrinkage and selection operator (LASSO) method and a rad-score was calculated. Multivariate logistic regression analysis was used to build a radiomics signature based on rad-score, participant's age, and gender, and a radiomics nomogram was used to represent this signature. The performance of the signature was evaluated by receiver operating characteristic (ROC) curve analysis, and the patient prognosis was stratified based on the TERT promoter mutation status and the radiomics signature.
RESULTS: Seven robust radiomics features were selected by LASSO and the radiomics signature showed good performance for predicting the TERT promoter mutation status, with an area under the curve (AUC) of 0.900 (0.832-0.946) and 0.873 (0.753-0.948) in the training and validation datasets. With a median overall survival time of 28.5 months, the radiomics signature stratified the LGG patients into two risk groups with significantly different prognosis (log-rank = 47.531, p<0.001).
CONCLUSION: The radiomics feature-based nomogram is a promising approach for predicting the TERT promoter mutation status preoperatively and evaluating the prognosis of lower-grade glioma patients non-invasively.
引用
- Lu, Li, Li, et al. A radiomics feature-based nomogram to predict telomerase reverse transcriptase promoter mutation status and the prognosis of lower-grade gliomas. Clin Radiol. 2022. PMID: 35595562. doi:10.1016/j.crad.2022.04.005
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。